Philips and World Stroke Organization partner to improve access to high-quality stroke care
10 Ottobre 2023 - 3:00PM
Philips and World Stroke Organization partner to improve access to
high-quality stroke care
October 10, 2023
- Two-year partnership focused on advocacy, education, and
raising awareness of stroke as a global healthcare challenge
- Philips’ leadership in the rapid end-to-end treatment of stroke
helping to improve patient outcomes and increase the efficiency of
treatment
Amsterdam, the Netherlands – Royal Philips
(NYSE: PHG, AEX: PHIA), a global leader in health technology, and
the World Stroke Organization (WSO), the world’s only global
non-governmental organization focused on stroke, today announced
the signing of a two-year partnership aimed at improving access to
high-quality stroke care. Building on their shared commitment to
delivering improvements in stroke prevention, treatment,
rehabilitation and support, Philips and WSO will leverage their
respective strengths to elevate the public understanding of stroke
as a global health issue, starting with joint initiatives on World
Stroke Day 2023 (October 29) to build greater public awareness,
which is fundamental to improving stroke patient outcomes. They
will also work together to support the implementation of innovative
treatment methods with the potential to transform the stroke care
pathway, where reducing the time between symptom onset and
effective treatment is critical to improving patient outcomes.
Announcing the partnership WSO President Prof Sheila Martins
said, “WSO is committed to accelerating the global implementation
of evidence-based treatment and care for stroke patients globally.
We know what works and we know that it takes every part of the
healthcare system, working together to bring quality care to every
patient.”
“Both innovation and public awareness are essential to improve
time-to-treatment and access to care for patients suffering a
stroke,” said Dr. Atul Gupta, Chief Medical Officer of Image Guided
Therapy at Philips. “Working closely with WSO, we can further shape
the future of neurovascular interventions and help provide
groundbreaking and effective high-quality care to patients so they
can resume normal life after a stroke.”
Stroke is the second leading cause of death and the leading
cause of disability worldwide, with around 12 million people
experiencing a stroke each year, including 6.5 million people who
die as a result. Those who do survive are often left with a complex
range of communication, cognitive, physical, and emotional
challenges for the rest of their life. To improve access to
high-quality care that reduces the burden stroke places on
individuals, and the financial and social impact it has on society,
Philips and WSO will collaborate across a range of stroke-related
areas. These include driving advocacy and policy based on the
latest clinical research and treatment guidelines to inform
government departments and healthcare providers about the latest
developments in stroke treatment, and supporting community
engagement.
Philips is a recognized leader in solutions that support the
rapid treatment of stroke to minimize its impact on patients,
including solutions for stroke monitoring and communication in
ambulances, tele-stroke patient assessment, artificial intelligence
(AI) supporting diagnostic imaging and analysis, image-guided
therapy, and neurological and cardiac monitoring and assessment.
The company also offers fully integrated angio suite systems
designed to facilitate a stroke procedure called mechanical
thrombectomy. During a thrombectomy, a specialized medical device
is used to physically remove or break up the clot, restoring blood
flow to the affected part of the brain. This quality-of-life-saving
procedure is often performed to minimize damage to brain tissue and
improve the chances of a patient's recovery after a stroke.
For further information, please contact:
Joost Maltha Philips Global Press Office Tel:
+31 6 10 55
8116 Email: joost.maltha@philips.com
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health
technology company focused on improving people's health and
well-being through meaningful innovation. Philips’ patient- and
people-centric innovation leverages advanced technology and deep
clinical and consumer insights to deliver personal health solutions
for consumers and professional health solutions for healthcare
providers and their patients in the hospital and the home.
Headquartered in the Netherlands, the company is a leader in
diagnostic imaging, ultrasound, image-guided therapy, monitoring
and enterprise informatics, as well as in personal health. Philips
generated 2022 sales of EUR 17.8 billion and employs approximately
71,500 employees with sales and services in more than 100
countries. News about Philips can be found at
www.philips.com/newscenter.
- A stroke patient rushed into the hospital
Grafico Azioni Koninklijke Philips NV (EU:PHIA)
Storico
Da Mar 2024 a Apr 2024
Grafico Azioni Koninklijke Philips NV (EU:PHIA)
Storico
Da Apr 2023 a Apr 2024
